Ann Miller
Director/Board Member presso INOVIO PHARMACEUTICALS, INC.
Patrimonio netto: 76 951 $ in data 31/03/2024
Posizioni attive di Ann Miller
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 25/03/2019 | - |
| Independent Dir/Board Member | 25/03/2019 | - | |
| ALLENA PHARMACEUTICALS, INC. | Director/Board Member | 05/10/2020 | - |
| Independent Dir/Board Member | 05/10/2020 | - |
Storia della carriera di Ann Miller
Precedenti posizioni note di Ann Miller
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Director/Board Member | 01/10/2019 | 31/12/2021 |
| Independent Dir/Board Member | 01/10/2019 | 31/12/2021 | |
| Sanofi SA | Sales & Marketing | 01/01/2012 | 01/09/2018 |
| EISAI CO., LTD. | Corporate Officer/Principal | 01/01/2009 | 01/01/2011 |
| AMGEN INC. | Sales & Marketing | 01/01/2002 | 01/01/2007 |
Formazione di Ann Miller
| Duke University | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Giappone | 2 |
| Francia | 2 |
Posizioni
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
| Sales & Marketing | 2 |
Settori
| Health Technology | 7 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| EISAI CO., LTD. | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
| Sanofi SA | Health Technology |
- Borsa valori
- Insiders
- Ann Miller
- Esperienza
